Change in coreceptor use correlates with disease progression in HIV-1--infected individuals
about
Severe anaemia is not associated with HIV-1 env gene characteristics in Malawian childrenThe coreceptor mutation CCR5Delta32 influences the dynamics of HIV epidemics and is selected for by HIVThe spread, treatment, and prevention of HIV-1: evolution of a global pandemicThe CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strainsSpontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype.Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 diseaseA putative cell surface receptor for anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamilyExpression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1.The B-oligomer of pertussis toxin inhibits human immunodeficiency virus type 1 replication at multiple stages.Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humansContribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infectionCCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremiaTwo orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infectionSelective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptorsEvolution of subtype C HIV-1 Env in a slowly progressing Zambian infant.Increased fidelity reduces poliovirus fitness and virulence under selective pressure in miceGenetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV InfectionsCCR5 Targeted Cell Therapy for HIV and Prevention of Viral EscapeHIV-1 envelope-receptor interactions required for macrophage infection and implications for current HIV-1 cure strategiesImpacts of humanized mouse models on the investigation of HIV-1 infection: illuminating the roles of viral accessory proteins in vivoHIV-1 functional cure: will the dream come true?HIV: cell binding and entryRecent developments in human immunodeficiency virus-1 latency researchNovel approaches to inhibit HIV entrySelective expansion of viral variants following experimental transmission of a reconstituted feline immunodeficiency virus quasispeciesHIV and the chemokine system: 10 years later.Structural and biological mimicry of protein surface recognition by / -peptide foldamersClinical significance of HIV-1 coreceptor usage.Engineering T Cells to Functionally Cure HIV-1 InfectionThe BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivityThe role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination?JM4 is a four-transmembrane protein binding to the CCR5 receptorA small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activityHIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 usePotent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivoInhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use
P2860
Q21261525-BA83ED9C-14ED-4C01-9228-663FB3DFE5C1Q22066237-044B5902-0024-4882-9ED7-CEB190D44F5DQ22241890-3E97B1BA-96DD-4BBA-92E8-2A3277D70A30Q24316964-6CBA8F34-1532-4EA2-AE5C-749517110324Q24523003-C3E24503-6246-494B-AC27-1E90DEF71FF9Q24524292-EA6D3AD8-84AF-44C5-ADD1-E5F96663CE2CQ24527277-1447FD92-2164-42EA-860C-214FEBE5669CQ24529578-17107B85-530F-4D07-9DCE-E9133019567CQ24531215-08C4A6CE-9A5C-4978-B2A0-2709EE60B226Q24531479-DC85470D-2A9A-4560-9F3D-C163B99DE9CAQ24537285-03DDF4A8-D07D-4FFE-ACA9-5CEC24CD14DBQ24550678-980CB9BD-CF6A-47AE-B4A2-ACA1365E140FQ24557545-9110522B-7FA5-4DBE-A26C-467A28474401Q24652969-794519E7-5988-411C-BC4E-354436E6669AQ24673389-CEF02719-552D-4090-B808-D5D246236E5AQ24682714-FB6E508F-A55F-4328-8086-D8B9CF03E1B7Q24815687-8FEAC456-403A-48DD-94D8-3C341DB47E9CQ24817069-74E9A556-4947-4893-B743-FBBEF02016C2Q26768628-4DB1664C-39E0-48FF-AE96-7455A530E43BQ26801498-EDEF94CB-2263-4B9E-9AAD-C3A25ADE75A7Q26825087-3D0B61CC-5C89-4C5D-B362-1B6D72DBE619Q26851152-A67A0E15-B293-4A68-9E39-E3919741AD42Q26865803-9DFE103C-2EEB-4F80-8C48-4DDFDDA60F5AQ27008983-8A3C1B0E-97EB-413A-8818-5839CFB0AD29Q27013114-3629121E-31C0-423D-8FDC-E5BD23E204E1Q27013957-AEE06168-FEAA-4CB3-AE6B-86BED53A46F2Q27318192-2B6582B1-02EC-4F12-AA9D-49C6BA7A36AFQ27473020-7161F412-8C46-4D1D-AC85-75519F4CC13FQ27657158-6517FEF8-2C3A-411D-AD27-A20C5FB1277AQ27691426-AD234116-708C-4456-9F30-B5EA1E1B490FQ28086801-C829884C-9DFD-43DD-8658-B8813B777E04Q28140341-498EAD08-688D-4F34-B1A3-3DED0AF9397CQ28201093-43ABC6ED-1A68-4BED-8CC1-7183AC39BF90Q28239006-DC3A8FEA-4010-4C62-96A8-FFB9D016E522Q28343321-5376AB5B-51D3-41EC-A8D8-BCA105945218Q28344746-DC8B26FF-8536-4983-90C2-5B4CA434B811Q28345395-36BC21D3-B935-44A3-9CEA-E020AE39B840Q28362194-67CE87D8-53C5-4628-919A-79381F5C2234Q28379182-8E4EFA83-A632-49FF-B532-F40830872DE7Q28379465-C9015E12-6A12-4102-B44F-B786EC1B50DC
P2860
Change in coreceptor use correlates with disease progression in HIV-1--infected individuals
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Change in coreceptor use corre ...... in HIV-1--infected individuals
@ast
Change in coreceptor use corre ...... in HIV-1--infected individuals
@en
type
label
Change in coreceptor use corre ...... in HIV-1--infected individuals
@ast
Change in coreceptor use corre ...... in HIV-1--infected individuals
@en
prefLabel
Change in coreceptor use corre ...... in HIV-1--infected individuals
@ast
Change in coreceptor use corre ...... in HIV-1--infected individuals
@en
P2093
P2860
P356
P1476
Change in coreceptor use corre ...... in HIV-1--infected individuals
@en
P2093
P2860
P304
P356
10.1084/JEM.185.4.621
P407
P577
1997-02-01T00:00:00Z